Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines

Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines

Current therapies are insufficient for metastatic prostate cancer (PCa) in men and dogs. As human castrate-resistant PCa shares several characteristics with the canine disease, comparative evaluation of novel therapeutic agents is of considerable value for both species. Novel isoquinolinamine FX-9 e...

Full description

Bibliographic Details
Main Authors: Jan Torben Schille, Ingo Nolte, Eva-Maria Packeiser, Laura Wiesner, Jens Ingo Hein, Franziska Weiner, Xiao-Feng Wu, Matthias Beller, Christian Junghanss, Hugo Murua Escobar
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:International Journal of Molecular Sciences
Subjects:
isoquinolinamine
prostate cancer
cell line
human
dog
anti-mitotic
chemotherapy
Online Access:https://www.mdpi.com/1422-0067/20/22/5567

Internet

https://www.mdpi.com/1422-0067/20/22/5567

Similar Items